LPA1LPA6

LPA1-LPA6 refers to the six lysophosphatidic acid receptors, a family of G protein-coupled receptors that bind the lipid mediator lysophosphatidic acid (LPA). In humans they are encoded by the LPAR1 through LPAR6 genes and are expressed in a wide range of tissues. These receptors transduce signals through multiple G proteins, leading to activation of intracellular pathways such as Rho/ROCK, phospholipase C, and MAP kinases, and thereby influence processes like cell proliferation, migration, survival, and cytoskeletal organization.

The receptor subtypes show both overlap and distinct functions. LPA1, LPA2, and LPA3 were identified earlier and share some signaling features but have different tissue distributions and physiological roles. LPA4, LPA5, and LPA6 were identified later and exhibit distinct pharmacology and coupling to G proteins, contributing to unique cellular responses compared with LPA1–LPA3. Ligand selectivity and downstream signaling can vary among the six receptors, reflecting specialization in physiological contexts.

Physiological roles for the LPA receptor family are broad. They participate in embryonic development, neural and vascular function, and wound healing, and modulate immune responses. Dysregulation of LPA signaling has been linked to fibrosis, neuropathic pain, and cancer progression through effects on cell migration, invasion, and survival.

Therapeutically, pharmacological antagonists and genetic models targeting LPA receptors are active areas of research, with interest in treating fibrotic diseases, chronic pain, and metastatic cancer.